EMEA-001214-PIP01-11-M11

Key facts

Invented name
Fasenra
Active substance
Benralizumab
Therapeutic area
Pneumology-allergology
Decision number
P/0129/2022
PIP number
EMEA-001214-PIP01-11-M11
Pharmaceutical form(s)
Solution for injection
Condition(s) / indication(s)
Treatment of asthma
Route(s) of administration
Subcutaneous use
Contact for public enquiries
AstraZeneca AB

E-mail: paediatrics@astrazeneca.com
Tel. +46 8553 24400

Decision type
PM: decision on the application for modification of an agreed PIP

Decision

Related content

How useful was this page?

Add your rating
Average
2 ratings